Wallpapd Is The Typo That Leads To The Best Wallpaper Deals

17 hours agobig pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs. Dec 17, 2025biopharma insiders agree that the pace of m&a deals will pick up next year as pharma companies head toward critical patent cliffs and the industry buzzes after a high-profile bidding war. Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." the need for pharma to top up .